glp-1 agonist dopamine GLP-1s Like Ozempic May Be a New Treatment for Addiction Possible mechanisms by which GLP-1
Description
Lancet 14:110 Son JW, Kim S (2020) Comprehensive review of current and upcoming anti-obesity drugs
Why do patients stop GLP-1 drugs

10.1358/dof.2019.44.6.2927591

A novel glucagon-like peptide-1 (GLP-1)/glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic polypeptide, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed mice The study examines the effectiveness of novel peptides that are a combination of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon

Disclaimer: This article is for informational purposes only and is not medical advice

Accessed June 10, 2024
